Thomas Peter Stagnaro
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Al Altomari | M | 65 | 20 years | |
| Robert Conway | M | 67 | 20 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kirk M. Warshaw | M | 66 | 9 years | |
| Marc L. Rose | M | 59 | 5 years | |
| Francis Raymond Salemme | M | 78 |
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 10 years |
| Scott M. Horvitz | M | 65 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 10 years |
| Arnold Kling | M | 66 | 10 years | |
| David C. U'Prichard | M | 75 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 4 years |
| Peter G. Tombros | M | 81 | 4 years | |
| Richard M. Soll | M | - |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 8 years |
| Anissa L. Leh | F | - | - | |
| Victor S. Sloan | M | - | 2 years | |
| Thomas M. Rossi | M | - | 6 years | |
| G. Kirk Raab | M | 88 | 6 years | |
| Frank M. Dougherty | M | 76 | 8 years | |
| Carleton A. Holstrom | M | 86 | 5 years | |
| Eugene Bauer | M | 81 | 4 years | |
| Paul Weiss | M | 66 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 3 years |
| Steven H. Kane | M | 71 | - | |
| John M. Stockmal | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Peter Stagnaro
- Personal Network
